News tagged with survival rates

Related topics: patients · cancer · breast cancer · lung cancer · cancer cells

Few immuno-oncology agents reach ASCO efficacy thresholds

(HealthDay)—Few modern, U.S. Food and Drug Administration-approved immuno-oncology agents have durable survival and response rates that are deemed significant by the American Society of Clinical Oncology (ASCO) value framework, ...

Jan 03, 2018
popularity1 comments 0

Subscribe to rss feed